Jaguar Health, Inc., a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, announced the release of a podcast interview conducted by Jaguar’s founder, president, and CEO, Lisa Conte, with The Wall Street Resource.
November 24, 2020
· 3 min read